1. Home
  2. CRVS vs IQ Comparison

CRVS vs IQ Comparison

Compare CRVS & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$12.68

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo iQIYI Inc.

IQ

iQIYI Inc.

HOLD

Current Price

$1.05

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
IQ
Founded
2014
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
CRVS
IQ
Price
$12.68
$1.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$30.17
$2.91
AVG Volume (30 Days)
1.3M
5.5M
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
48.04
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$0.28
Revenue Next Year
N/A
$3.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$0.98
52 Week High
$26.95
$2.76

Technical Indicators

Market Signals
Indicator
CRVS
IQ
Relative Strength Index (RSI) 52.58 41.53
Support Level $11.13 $1.03
Resistance Level $14.00 $1.19
Average True Range (ATR) 0.66 0.04
MACD 0.24 0.00
Stochastic Oscillator 83.26 48.58

Price Performance

Historical Comparison
CRVS
IQ

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About IQ iQIYI Inc.

Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.

Share on Social Networks: